Literature DB >> 14752065

Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.

Susan E Krown1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14752065     DOI： 10.1200/JCO.2004.08.064

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  29 in total

1.  Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.

Authors:  Phillipo L Chalya; Fidelis Mbunda; Peter F Rambau; Hyasinta Jaka; Nestory Masalu; Mariam Mirambo; Martha F Mushi; Samuel E Kalluvya
Journal:  BMC Res Notes       Date:  2015-09-15

2.  Management of HIV associated Kaposi's sarcoma in Malawi.

Authors:  Yohannie Mlombe
Journal:  Malawi Med J       Date:  2008-12       Impact factor: 0.875

Review 3.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

Review 4.  A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

Authors:  Dorothy E Dow; Coleen K Cunningham; Ann M Buchanan
Journal:  J Pediatric Infect Dis Soc       Date:  2013-09-04       Impact factor: 3.164

5.  Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

Authors:  Thomas S Uldrick; Kathleen M Wyvill; Pallavi Kumar; Deirdre O'Mahony; Wendy Bernstein; Karen Aleman; Mark N Polizzotto; Seth M Steinberg; Stefania Pittaluga; Vickie Marshall; Denise Whitby; Richard F Little; Robert Yarchoan
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

6.  A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.

Authors:  Anisa Mosam; Fahmida Shaik; Thomas S Uldrick; Tonya Esterhuizen; Gerald H Friedland; David T Scadden; Jamila Aboobaker; Hoosen M Coovadia
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

7.  Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.

Authors:  Landon N Olp; Veenu Minhas; Clement Gondwe; Chipepo Kankasa; Janet Wojcicki; Charles Mitchell; John T West; Charles Wood
Journal:  J Natl Cancer Inst       Date:  2015-07-16       Impact factor: 13.506

8.  Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.

Authors:  Richard F Little; James M Pluda; Kathleen M Wyvill; Isaac R Rodriguez-Chavez; Giovanna Tosato; Andrew T Catanzaro; Seth M Steinberg; Robert Yarchoan
Journal:  Blood       Date:  2006-02-28       Impact factor: 22.113

9.  AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.

Authors:  Kathryn M Chu; Gcina Mahlangeni; Sarah Swannet; Nathan P Ford; Andrew Boulle; Gilles Van Cutsem
Journal:  J Int AIDS Soc       Date:  2010-07-08       Impact factor: 5.396

Review 10.  Lung Malignancies in HIV Infection.

Authors:  Keith Sigel; Robert Pitts; Kristina Crothers
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.